Sociedad Americana de Hirudoterapia

Implantable Doppler Removal After Free Flap Monitoring Among Head and Neck Microvascular Surgeons.

Research article published in The Laryngoscope (2021)

Última actualización: 18 de junio de 2026Revisado por: ASH Editorial Board
Artículo de investigación — revisión de evidenciaReferencia del artículo
Evidence: Research reportEnsayos clínicosOng et al. · The Laryngoscope, 2021

Abstract

OBJECTIVE: Investigate current practice patterns of head and neck microvascular reconstructive surgeons when removing an implantable Doppler after free flap surgery. STUDY DESIGN: Cross-sectional survey study. METHODS: Survey distributed to head and neck microvascular reconstructive surgeons. Data regarding years performing free tissue transfer, case numbers, management of implantable Doppler wire, and complications were collected. RESULTS: Eighty-five responses were analyzed (38,000 cases). Sixty-six responders (77.6%) use an implantable Doppler for postoperative monitoring, with 97% using the Cook-Swartz Doppler Flow Monitoring System. Among this group, 65.2% pull the wire after monitoring was complete, 3% cut the wire, and 31.8% have both cut and pulled the wire. Of those who have cut and pulled the wire, 48% report cutting and pulling the wire with equal frequency, 43% formerly pulled the wire and now cut the wire, and 9% previously cut the wire but now pull the wire. Of those who pull the wire, there were two injuries to the pedicle requiring return to the operating for flap salvage, and one acute venous congestion. Of the nine who previously pulled the wire, six (67%) cited concerns with major bleeding/flap compromise as the reason for cutting the wire. CONCLUSION: In this study, most surgeons use an implantable Doppler for monitoring of free flaps postoperatively. In extremely rare instances, pulling the implantable Doppler wire has resulted in flap compromise necessitating revision of the vascular anastomosis. Cutting the wire and leaving the proximal portion in the surgical site has been adopted as a management option. LEVEL OF EVIDENCE: 4 Laryngoscope, 132:554-559, 2022.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsCross-Sectional StudiesDevice RemovalFree Tissue FlapsHumansLaser-Doppler FlowmetryMicrocirculationOtorhinolaryngologic Surgical ProceduresPostoperative CarePractice Patterns, Physicians'Plastic Surgery ProceduresSurveys and QuestionnairesVascular Patency

Resumen

Investigate current practice patterns of head and neck microvascular reconstructive surgeons when removing an implantable Doppler after free flap surgery. Cross-sectional survey study.

Por qué esto importa para la hirudoterapia

Este estudio transversal investigó los patrones de práctica de cirujanos reconstructivos microvasculares de cabeza y cuello en relación con el retiro de alambres Doppler implantables tras cirugía de colgajo libre. Las complicaciones documentadas de la tracción del alambre incluyeron dos lesiones del pedículo que requirieron reintervención quirúrgica para salvamento del colgajo y un caso de congestión venosa aguda. El resumen señala que algunos cirujanos optaron por cortar el alambre debido a la preocupación por sangrado mayor o compromiso del colgajo. Sin embargo, este estudio se enfoca estrictamente en el manejo del dispositivo Doppler y no menciona sanguijuelas, hirudoterapia ni ninguna terapia de salvamento específica para la congestión venosa, lo que hace que su relevancia para la Sociedad Americana de Hirudoterapia sea completamente indirecta.

Citación

Implantable Doppler Removal After Free Flap Monitoring Among Head and Neck Microvascular Surgeons.

Ong et al. · The Laryngoscope, 2021

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 28, 2026 · Última actualización del sitio: 18 de junio de 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.